US President Donald Trump signed an executive order on Tuesday to restrict gender transition procedures for individuals under the age of 19.
Trump’s executive order marks the latest in a series of actions by the Trump administration aimed at limiting transgender healthcare access since his return to office.
Key Aspects of Trump’s Executive Order on Gender Transition
Prohibition of Federal Funding for Gender Transitions
The order declares that the US government will no longer “fund, sponsor, promote, assist, or support the so-called ‘transition’ of a child from one sex to another.” This includes banning federal funding for gender transition procedures under key healthcare programs:
- Medicaid: Health insurance for low-income families.
- Medicare: Health insurance for retirees.
- Department of Defense Health Insurance: Covers approximately 2 million children.
Crackdown on Medical Procedures
The order specifically targets what Trump referred to as “chemical and surgical mutilation,” including:
- Puberty blockers.
- Hormone therapies.
- Gender-altering surgeries.
Enforcement of Existing Laws
The administration pledged to “rigorously enforce all laws that prohibit or limit these destructive and life-altering procedures,” despite the absence of a nationwide ban on gender-affirming care for minors.
Legal Recourse for Families
Trump announced plans to collaborate with Congress to draft legislation allowing children and their parents to sue doctors who perform gender transition surgeries on minors.
The executive order aligns with Trump’s recent statements, including his inauguration speech, where he affirmed that his administration would only recognize two genders: male and female. This stance has placed the issue at the centre of America’s ongoing culture wars.
Trump reiterated his position during the Davos forum last week, stating that gender transition surgeries “will occur very rarely” under his administration. His order reflects a broader trend among Republican-led states, with 24 states having already enacted laws restricting gender-affirming care for minors.
The issue has sparked intense debate across the country. In December, US Supreme Court justices clashed over a Tennessee law banning puberty blockers and hormone therapy for individuals under 18. Critics argue that such restrictions infringe on the rights of transgender youth and their families, while supporters claim they protect children from irreversible medical procedures.
